
    
      The purpose of study is to determine if modafinil promotes cocaine abstinence and reduces HRB
      in cocaine dependent subjects. Modafinil (300 mg/day) or placebo will be administered in an
      8-week double-blind trial to patients meeting diagnostic criteria for cocaine dependence in
      conjunction with Cognitive Behavioral Therapy (CBT).
    
  